Saccharo is a biotech start-up in the immuno-oncology space that develops therapeutic products for the treatment of cancer and other novel diseases. Saccharo discovered a polysaccharide that surrounds human cancer cells. The Sacchario approach has a mechanism of action that allows drugs to have multiple killing effects, a predicted safetyprofile, a broad therapeutic window, and applications to many cancers.Saccharo was established in 2017 by Sherry Martin-Moe and Gregory Moe in Oakland, California.

Therapeutics

Health Care

Biotechnology

Saccharo

Sherry Martin-Moe

Margaret Kim

Corine Dietz-Muegge

Tom Boone

Greg Moe

Directors Team

Leadership Team

Teams at Saccharo

Directors Team

Leadership Team